Author

M Hedibel

Observed name: M. Hedibel

Institution: University of Algiers Benyoucef Benkhedda

Observed institution: University of Algiers Benyoucef Benkhedda

OpenAlex ID: A5093565213

EE290 Cost Comparison Between the Use of Pertuzumab-Trastuzumab SC and IV Formulations to Treat HER2+ Breast Cancer Patients in Algeria

2024 · M Hedibel, HA Bouchebout, et al. · Value in Health

HPR28 Access to Advanced Therapy Medicinal Products (ATMPs) in Low- and Middle-Income Countries LMICs: A Systematic Review

2024 · M Hedibel, N Benakila, et al. · Value in Health

EE642 Cost-Effectiveness of Febuxostat 120/80 Mg as a Second-Line After Allopurinol 100/300MG in Gout Patients in Algeria

2024 · N Alkhatib, M Hedibel, et al. · Value in Health

HPR100 Orphan Drugs in Algeria and Six Other Countries: A Cross Comparison Study

2023 · R. Chaouch, A. Sahnoun, et al. · Value in Health

HPR207 Moving to Outcomes-Based Agreements in Algeria: Sharing Experiences Between Saudi Arabia and Algeria

2023 · G. Elsisi, A. Al Jedai, et al. · Value in Health

Works count: 5

Citation count:

H-index:

I10-index: